Preclinical effectiveness of selective inhibitor of IS-1/2 NT157 in osteosarcoma cell lines
Jump to navigation
Jump to search
Target Article[edit | edit source]
Preclinical effectiveness of selective inhibitor of IS-1/2 NT157 in osteosarcoma cell lines; C Garofalo, M Capristo, C Mancarellaae; 2015; doi_citing_unknown
Retraction[edit | edit source]
Positive and Negative Roles of p85a and p85ß Regulatory Subunits of Phosphoinositide 3-Kinase in Insulin Signaling ; Kohjiro Ueki David A Fruman Claudine M Yballe Mathias Fasshauer Johannes Klein Tomoichiro Asano; 09/22/2003
Citation piece[edit | edit source]
Note: Open to append information.